Literature DB >> 18964303

Gene-specific control of the TLR-induced inflammatory response.

Simmie L Foster1, Ruslan Medzhitov.   

Abstract

Toll-like receptors (TLRs) induce a complex inflammatory response that functions to alert the body to infection, neutralize pathogens, and repair damaged tissues. An excessive or persistent inflammatory response can be fatal, so multiple regulatory mechanisms have evolved to control the extent and duration of inflammation. Our current understanding of the control of inflammation is based on negative regulation of TLR signaling. However, TLR-induced genes have diverse functions, and control of signaling pathways does not allow for groups of genes with distinct functions to be differentially regulated. Recent evidence suggests that many inflammatory genes are instead regulated by epigenetic modifications to individual promoters. This level of control allows a single gene to be expressed or silenced according to its function, irrespective of other genes induced by the same receptor, and therefore is "gene-specific." Gene-specific control of the TLR-induced inflammatory response is an emerging paradigm in the study of inflammation, and may provide the basis for selective modulation of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18964303      PMCID: PMC3252731          DOI: 10.1016/j.clim.2008.08.015

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  55 in total

Review 1.  Functional consequences of histone modifications.

Authors:  Masayoshi Iizuka; M Mitchell Smith
Journal:  Curr Opin Genet Dev       Date:  2003-04       Impact factor: 5.578

Review 2.  Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Authors:  Marina A Dobrovolskaia; Stefanie N Vogel
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

Review 3.  A BAF-centred view of the immune system.

Authors:  Tian Chi
Journal:  Nat Rev Immunol       Date:  2004-12       Impact factor: 53.106

Review 4.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

Review 5.  Neurohormonal host defense in endotoxin shock.

Authors:  I Berczi
Journal:  Ann N Y Acad Sci       Date:  1998-05-01       Impact factor: 5.691

Review 6.  The nonspecific nature of endotoxin tolerance.

Authors:  J M Cavaillon
Journal:  Trends Microbiol       Date:  1995-08       Impact factor: 17.079

7.  Histone deacetylase activities are required for innate immune cell control of Th1 but not Th2 effector cell function.

Authors:  Jennifer L Brogdon; Yongyao Xu; Susanne J Szabo; Shaojian An; Francis Buxton; Dalia Cohen; Qian Huang
Journal:  Blood       Date:  2006-09-28       Impact factor: 22.113

8.  A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways.

Authors:  Shintaro Sato; Osamu Takeuchi; Takashi Fujita; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Int Immunol       Date:  2002-07       Impact factor: 4.823

9.  TOLERANCE TO BACTERIAL PYROGENS : I. FACTORS INFLUENCING ITS DEVELOPMENT.

Authors:  P B Beeson
Journal:  J Exp Med       Date:  1947-06-30       Impact factor: 14.307

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  90 in total

Review 1.  Gene-specific epigenetic regulation in serious infections with systemic inflammation.

Authors:  Charles E McCall; Barbara Yoza; Tiefu Liu; Mohamed El Gazzar
Journal:  J Innate Immun       Date:  2010-04-27       Impact factor: 7.349

Review 2.  HMGB1 and microparticles as mediators of the immune response to cell death.

Authors:  David S Pisetsky; Julie Gauley; Anirudh J Ullal
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

3.  Facultative heterochromatin formation at the IL-1 beta promoter in LPS tolerance and sepsis.

Authors:  Barbara K Yoza; Charles E McCall
Journal:  Cytokine       Date:  2011-02       Impact factor: 3.861

4.  Immunological priming requires regulatory T cells and IL-10-producing macrophages to accelerate resolution from severe lung inflammation.

Authors:  Neil R Aggarwal; Kenji Tsushima; Yoshiki Eto; Ashutosh Tripathi; Pooja Mandke; Jason R Mock; Brian T Garibaldi; Benjamin D Singer; Venkataramana K Sidhaye; Maureen R Horton; Landon S King; Franco R D'Alessio
Journal:  J Immunol       Date:  2014-03-31       Impact factor: 5.422

5.  ABCA1 promotes the efflux of bacterial LPS from macrophages and accelerates recovery from LPS-induced tolerance.

Authors:  Patricia A Thompson; Karine C Gauthier; Alan W Varley; Richard L Kitchens
Journal:  J Lipid Res       Date:  2010-05-15       Impact factor: 5.922

Review 6.  Transcriptional control of the inflammatory response.

Authors:  Ruslan Medzhitov; Tiffany Horng
Journal:  Nat Rev Immunol       Date:  2009-10       Impact factor: 53.106

Review 7.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 8.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

Review 9.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

Review 10.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.